XGN news

Latest 1 stories · newest Aug 4, 2026

XGN

Exagen reports record Q2 revenue, lifts 2026 guidance

Exagen Inc. increased full-year revenue guidance to $72M-$75M after reporting a record $19.9M in Q2 revenue, driven by higher test volumes and ASPs. The diagnostics company narrowed its adjusted EBITDA loss to $0.1 million, signaling progress towards sustainable profitability.

Guidance|Earnings Aug 4, 2026 sentiment +0.70 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same XGN feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/XGN/newsSTART FREE